Literature DB >> 20431578

Proposed controlled trials of phosphate reduction in CKD: which whey should we go?

John T Daugirdas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20431578     DOI： 10.1038/ki.2010.52

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


× No keyword cloud information.
  3 in total

1.  Assessment of oral health status and inflammatory markers in end stage chronic kidney disease patients: A cross-sectional study.

Authors:  Lokesh Sharma; Devina Pradhan; Rahul Srivastava; Manas Shukla; Omveer Singh
Journal:  J Family Med Prim Care       Date:  2020-05-31

Review 2.  Management of natural and added dietary phosphorus burden in kidney disease.

Authors:  Adamasco Cupisti; Kamyar Kalantar-Zadeh
Journal:  Semin Nephrol       Date:  2013-03       Impact factor: 5.299

Review 3.  Phosphate control in dialysis.

Authors:  Adamasco Cupisti; Maurizio Gallieni; Maria Antonietta Rizzo; Stefania Caria; Mario Meola; Piergiorgio Bolasco
Journal:  Int J Nephrol Renovasc Dis       Date:  2013-10-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.